XERISOL

Serial Number 90359499
Registration 7559452
700

Registration Progress

Application Filed
Dec 4, 2020
Under Examination
Aug 24, 2021
Approved for Publication
Jun 29, 2021
Published for Opposition
Jun 29, 2021
Registered
Nov 5, 2024

Trademark Image

XERISOL

Basic Information

Serial Number
90359499
Registration Number
7559452
Filing Date
December 4, 2020
Registration Date
November 5, 2024
Published for Opposition
June 29, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 5, 2024
Registration
Registered
Classes
042

Rights Holder

Xeris Pharmaceuticals, Inc.

03
Address
180 N LaSalle Street, Suite 1810
Chicago, IL 60601

Ownership History

Xeris Pharmaceuticals, Inc.

Original Applicant
03
Chicago, IL

Xeris Pharmaceuticals, Inc.

Owner at Publication
03
Chicago, IL

Xeris Pharmaceuticals, Inc.

Original Registrant
03
Chicago, IL

Legal Representation

Attorney
Tracy-Gene G. Durkin

USPTO Deadlines

Next Deadline
1922 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-11-05)
Due Date
November 05, 2030
Grace Period Ends
May 05, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

43 events
Date Code Type Description Documents
Nov 5, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 5, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 3, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 3, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Oct 2, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 2, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 1, 2024 IUAF S USE AMENDMENT FILED Loading...
Aug 1, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Feb 14, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 13, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Feb 13, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Feb 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 25, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 23, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 23, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 23, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 2, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 31, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 31, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 31, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 23, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
May 31, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 27, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 27, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
May 27, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 19, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Dec 18, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 16, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 16, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 16, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 24, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 29, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 29, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 9, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 26, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
May 26, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
May 26, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
May 26, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 26, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
May 24, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 12, 2021 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Feb 10, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 8, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development; pharmaceutical drug formulation and development services; providing information on drug technology platforms for the formulation and development of drugs and biologics
First Use Anywhere: 20190000
First Use in Commerce: 20190000

Classification

International Classes
042